JP2012519724A5 - - Google Patents

Download PDF

Info

Publication number
JP2012519724A5
JP2012519724A5 JP2011553432A JP2011553432A JP2012519724A5 JP 2012519724 A5 JP2012519724 A5 JP 2012519724A5 JP 2011553432 A JP2011553432 A JP 2011553432A JP 2011553432 A JP2011553432 A JP 2011553432A JP 2012519724 A5 JP2012519724 A5 JP 2012519724A5
Authority
JP
Japan
Prior art keywords
ctb
hapten
subunit
inducing
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011553432A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012519724A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/052997 external-priority patent/WO2010103017A2/en
Publication of JP2012519724A publication Critical patent/JP2012519724A/ja
Publication of JP2012519724A5 publication Critical patent/JP2012519724A5/ja
Pending legal-status Critical Current

Links

JP2011553432A 2009-03-09 2010-03-09 シグナルペプチドを担体として有する細菌毒素とのハプテン‐担体抱合体及び免疫原性組成物としてのその使用 Pending JP2012519724A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20962909P 2009-03-09 2009-03-09
US61/209,629 2009-03-09
PCT/EP2010/052997 WO2010103017A2 (en) 2009-03-09 2010-03-09 Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions

Publications (2)

Publication Number Publication Date
JP2012519724A JP2012519724A (ja) 2012-08-30
JP2012519724A5 true JP2012519724A5 (enExample) 2013-04-25

Family

ID=42555592

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011553432A Pending JP2012519724A (ja) 2009-03-09 2010-03-09 シグナルペプチドを担体として有する細菌毒素とのハプテン‐担体抱合体及び免疫原性組成物としてのその使用

Country Status (9)

Country Link
US (1) US20120100171A1 (enExample)
EP (1) EP2405943A2 (enExample)
JP (1) JP2012519724A (enExample)
KR (1) KR20120022760A (enExample)
CN (1) CN102427828A (enExample)
CA (1) CA2754592A1 (enExample)
MX (1) MX2011009359A (enExample)
RU (1) RU2011140858A (enExample)
WO (1) WO2010103017A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8728478B2 (en) * 2008-09-03 2014-05-20 Board Of Trustees Of Michigan State University Immunogenic Escherichia coli heat stable enterotoxin
ES2732815T3 (es) 2009-05-22 2019-11-26 Genocea Biosciences Inc Vacunas frente al virus del herpes simple de tipo 2: composiciones y métodos para provocar una respuesta inmunitaria
EP2482838A4 (en) * 2009-09-30 2013-04-10 Toxcure Inc USE OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF SUBSTANCE DEPENDENCE
CA2856697A1 (en) 2010-11-24 2012-06-07 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
WO2012125720A2 (en) 2011-03-14 2012-09-20 University Of Louisville Research Foundation, Inc. Polypeptides having immunoactivating activity and methods of producing the same
EP3313866B1 (en) 2015-06-29 2024-11-20 University Of Louisville Research Foundation, Inc. Compositions and methods for treating cancer and promoting wound healing
JP2019537555A (ja) 2016-09-28 2019-12-26 ジェノセア バイオサイエンシーズ, インコーポレイテッド ヘルペスを処置するための方法および組成物
WO2018060351A1 (en) * 2016-09-29 2018-04-05 Ipsen Biopharm Limited Hybrid neurotoxins
EP3973253A4 (en) * 2019-05-20 2022-08-10 Siemens Healthcare Diagnostics, Inc. PROCEDURE FOR DETECTING ABERRANTIC RESULTS DUE TO INCOMPLETE DELIVERY OF A POLYHAPTEN REAGENT IN IMMUNOASSAYS
JP7555363B2 (ja) 2019-07-03 2024-09-24 インターベット インターナショナル ベー. フェー. マイコトキシン症に対する防御のためのコンジュゲート化デオキシニバレノール
US12343375B2 (en) 2021-02-09 2025-07-01 University Of Louisville Research Foundation, Inc. Spray dried formulation of a cholera toxin B subunit variant

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171568A (en) 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US4883761A (en) 1986-03-25 1989-11-28 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
EP0251575B2 (en) 1986-06-17 2002-11-13 Chiron Corporation Hepatitis delta diagnostics and vaccines, their preparation and use
WO1989004669A1 (en) 1987-11-18 1989-06-01 Chiron Corporation Nanbv diagnostics and vaccines
WO1990011089A1 (en) 1989-03-17 1990-10-04 Chiron Corporation Nanbv diagnostics and vaccines
ATE211772T1 (de) 1989-05-18 2002-01-15 Chiron Corp Nanbv-diagnostika: polynukleotide, geeignet für reihenuntersuchungen auf hepatitis c-virus
US5840307A (en) * 1995-03-31 1998-11-24 Immulogic Pharmacuetical Corp. Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
US5876727A (en) 1995-03-31 1999-03-02 Immulogic Pharmaceutical Corporation Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
US20020032316A1 (en) 1995-03-31 2002-03-14 Cantab Pharmaceuticals Research Limited Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
FR2768747B1 (fr) 1997-09-19 2000-12-01 Pasteur Institut Acides nucleiques, cellules recombinantes, et procede de preparation de compositions immunogenes
CN1231586C (zh) * 2003-04-15 2005-12-14 中国科学院微生物研究所 一种多形汉逊酵母表达重组霍乱毒素b亚单位基因及其应用
GB0325494D0 (en) * 2003-10-31 2003-12-03 Sbl Vaccin Ab Expression system

Similar Documents

Publication Publication Date Title
JP2012519724A5 (enExample)
CN106659777A8 (zh) 免疫原性组合产品
JP2012126742A5 (enExample)
ES2563646T3 (es) Composiciones y métodos relacionados con variantes de la proteína A (SpA)
JP2008530245A5 (enExample)
JP2012507294A5 (enExample)
JP2017048194A5 (enExample)
JP2013172734A5 (enExample)
JP2013518052A5 (enExample)
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
JP2011250797A5 (enExample)
RU2017104529A (ru) Композиции neisseria meningitidis и способы их применения
JP2016509011A5 (enExample)
WO2014018858A3 (en) Multimeric fusion protein vaccine and immunotherapeutic
JP2010011868A5 (enExample)
JP2013517783A5 (enExample)
JP2008529558A5 (enExample)
EA201391240A1 (ru) Слитые белки и комбинированные вакцины, содержащие белок е и пилин а haemophilus influenza
MX2019003682A (es) Antigenos de consenso del virus sincitial respiratorio humano, constructos de acido nucleico y vacunas hechas de estos, y metodos para utilizarlas.
JP2011530309A5 (enExample)
RU2015141214A (ru) Вакцины против Chlamydia sp.
JP2016514713A5 (enExample)
JP2013510169A5 (enExample)
JP2011528897A5 (enExample)
WO2008054535A3 (en) Novel influenza m2 vaccines